248 related articles for article (PubMed ID: 29273846)
1. Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?
Frau J; Villar LM; Sardu C; Secci MA; Schirru L; Ferraro D; Coghe G; Lorefice L; Fenu G; Bedin R; Sola P; Marrosu MG; Cocco E
J Neurol; 2018 Feb; 265(2):424-430. PubMed ID: 29273846
[TBL] [Abstract][Full Text] [Related]
2. Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes.
Magraner MJ; Bosca I; Simó-Castelló M; García-Martí G; Alberich-Bayarri A; Coret F; Alvarez-Cermeño JC; Martí-Bonmatí L; Villar LM; Casanova B
Neuroradiology; 2012 Jan; 54(1):5-12. PubMed ID: 21327771
[TBL] [Abstract][Full Text] [Related]
3. CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosis.
Villar LM; Masterman T; Casanova B; Gómez-Rial J; Espiño M; Sádaba MC; González-Porqué P; Coret F; Alvarez-Cermeño JC
J Neuroimmunol; 2009 Jun; 211(1-2):101-4. PubMed ID: 19443047
[TBL] [Abstract][Full Text] [Related]
4. Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome.
Monreal E; Sainz de la Maza S; Costa-Frossard L; Walo-Delgado P; Zamora J; Fernández-Velasco JI; Villarrubia N; Espiño M; Lourido D; Lapuente P; Toboso I; Álvarez-Cermeño JC; Masjuan J; Villar LM
Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34301819
[TBL] [Abstract][Full Text] [Related]
5. Influence of oligoclonal IgM specificity in multiple sclerosis disease course.
Villar L; García-Barragán N; Espiño M; Roldán E; Sádaba M; Gómez-Rial J; González-Porqué P; Alvarez-Cermeño J
Mult Scler; 2008 Mar; 14(2):183-7. PubMed ID: 17942517
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal lipid-specific oligoclonal IgM synthesis associates with retinal axonal loss in multiple sclerosis.
Álvarez-Cermeño JC; Muñoz-Negrete FJ; Costa-Frossard L; Sainz de la Maza S; Villar LM; Rebolleda G
J Neurol Sci; 2016 Jan; 360():41-4. PubMed ID: 26723970
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis patients with anti-lipid oligoclonal IgM show early favourable response to immunomodulatory treatment.
García-Barragán N; Villar LM; Espiño M; Sádaba MC; González-Porqué P; Alvarez-Cermeño JC
Eur J Neurol; 2009 Mar; 16(3):380-5. PubMed ID: 19175382
[TBL] [Abstract][Full Text] [Related]
8. Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis.
Gasperi C; Salmen A; Antony G; Bayas A; Heesen C; Kümpfel T; Linker RA; Paul F; Stangel M; Tackenberg B; Bergh FT; Warnke C; Weber F; Wiendl H; Wildemann B; Zettl UK; Ziemann U; Zipp F; Tumani H; Gold R; Hemmer B;
JAMA Neurol; 2019 Jul; 76(7):841-849. PubMed ID: 31034002
[TBL] [Abstract][Full Text] [Related]
9. Oligoclonal IgM bands are a promising biomarker for long-term cognitive outcomes in multiple sclerosis.
Coll-Martinez C; Quintana E; Buxó M; Salavedra-Pont J; Gasull-Vicens L; Quiroga-Varela A; Costa-Frossard L; Villar LM; Fernández-Díaz E; Gracia J; Aladro Y; Méndez-Burgos A; Cerezo M; Ramió-Torrentà L; Gich J
Mult Scler Relat Disord; 2022 Dec; 68():104397. PubMed ID: 36544326
[TBL] [Abstract][Full Text] [Related]
10. Intrathecal IgM Synthesis Is Associated with Spinal Cord Manifestation and Neuronal Injury in Early MS.
Oechtering J; Lincke T; Schaedelin S; Décard BF; Maceski A; Orleth A; Meier S; Willemse E; Buchmann A; Khalil M; Derfuss T; Benkert P; Heijnen I; Regeniter A; Müller S; Achtnichts L; Lalive P; Salmen A; Pot C; Gobbi C; Kappos L; Granziera C; Leppert D; Schlaeger R; Lieb JM; Kuhle J;
Ann Neurol; 2022 Jun; 91(6):814-820. PubMed ID: 35293622
[TBL] [Abstract][Full Text] [Related]
11. Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status.
Balnytė R; Rastenytė D; Vaitkus A; Skrodenienė E; Vitkauskienė A; Ulozienė I
Medicina (Kaunas); 2016; 52(4):217-222. PubMed ID: 27515835
[TBL] [Abstract][Full Text] [Related]
12. Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis.
Coll-Martinez C; Quintana E; Salavedra-Pont J; Buxó M; González-Del-Rio M; Gómez I; Muñoz-San Martín M; Villar LM; Álvarez-Bravo G; Robles-Cedeño R; Ramió-Torrentà L; Gich J
Brain Behav; 2021 Dec; 11(12):e2405. PubMed ID: 34796675
[TBL] [Abstract][Full Text] [Related]
13. Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability.
Capuano R; Zubizarreta I; Alba-Arbalat S; Sepulveda M; Sola-Valls N; Pulido-Valdeolivas I; Andorra M; Martinez-Heras E; Solana E; Lopez-Soley E; Montejo C; Blanco Y; Fernández-Velasco JI; Gallo A; Bisecco A; Villoslada P; Saiz A; Llufriu S; Villar LM; Martinez-Lapiscina EH
Mult Scler; 2021 Oct; 27(11):1706-1716. PubMed ID: 33433258
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal IgM synthesis is a prognostic factor in multiple sclerosis.
Villar LM; Masjuan J; González-Porqué P; Plaza J; Sádaba MC; Roldán E; Bootello A; Alvarez-Cermeño JC
Ann Neurol; 2003 Feb; 53(2):222-6. PubMed ID: 12557289
[TBL] [Abstract][Full Text] [Related]
15. Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis.
Alcalá Vicente C; Lacruz L; Gascón F; Carratalà S; Quintanilla-Bordás C; Sanz MT; Carcelén-Gadea M; Mallada J; Carreres J; Gabaldón Torres L; Dominguez JA; Cañizares E; Gil-Perotin S; Cubas L; Gasqué Rubio R; Castillo-Villalba J; Pérez-Miralles FC; Casanova B
Front Neurol; 2022; 13():991596. PubMed ID: 36388220
[TBL] [Abstract][Full Text] [Related]
16. A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease.
Mandrioli J; Sola P; Bedin R; Gambini M; Merelli E
J Neurol; 2008 Jul; 255(7):1023-31. PubMed ID: 18535872
[TBL] [Abstract][Full Text] [Related]
17. Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromes.
Villar LM; Espiño M; Roldán E; Marín N; Costa-Frossard L; Muriel A; Alvarez-Cermeño JC
Mult Scler; 2011 Jun; 17(6):690-4. PubMed ID: 21436320
[TBL] [Abstract][Full Text] [Related]
18. Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis.
Monreal E; Fernández-Velasco JI; García-Soidán A; Sainz de la Maza S; Espiño M; Villarrubia N; Rodríguez-Jorge F; Chico-García JL; Sainz-Amo R; Masjuan J; Costa-Frossard L; Villar LM
Front Immunol; 2023; 14():1288169. PubMed ID: 37954589
[TBL] [Abstract][Full Text] [Related]
19. Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple sclerosis.
Rosenstein I; Rasch S; Axelsson M; Novakova L; Blennow K; Zetterberg H; Lycke J
Front Immunol; 2022; 13():967953. PubMed ID: 36032114
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis.
Stauch C; Reiber H; Rauchenzauner M; Strasak A; Pohl D; Hanefeld F; Gärtner J; Rostásy KM
Mult Scler; 2011 Mar; 17(3):327-34. PubMed ID: 21123302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
